Bristol-Myers Squibb is a drug manufacturers - general company in the healthcare sector trading on NYSE, led by CEO Christopher S. Boerner, with a market cap of $121.42B.
Common questions about Bristol-Myers Squibb
Bristol-Myers Squibb is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $10.9B.
Bristol-Myers Squibb has approximately 34,100 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.